Home » Topics » BioWorld Science

BioWorld Science
RSS

FLAP inhibitor from Bayer inhibits allergen-induced bronchoconstriction in atopic asthmatics

May 28, 1997

Losartan effective in chronic renal allograft rejection

May 28, 1997

Promising results with DuPont Merck's DMP-266 reported

May 28, 1997

Merck & Co. acquires majority share of Gentili

May 28, 1997

AltaRex initiates U.S. phase IIb trial with Ovarex

May 28, 1997

Use of labetalol in renal transplant patients discouraged

May 28, 1997

Retrospective evaluation of immunosuppressive therapy for pediatric IBD

May 28, 1997

ProCyte launches GraftCyte products

May 28, 1997

Oral methotrexate for severe IBD in children

May 28, 1997

Safety and efficacy of oral budesonide (Budenofalk) in Crohn's disease and collagenous colitis

May 28, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...